• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

February 25, 2011: Vaccines and Related Biological Products Advisory Committee Meeting Agenda

AGENDA

Food and Drug Administration
Center for Biologics Evaluation and Research
Vaccines and Related Biological Products Advisory Committee
125th Meeting

February 25, 2011

DoubleTree Hotel Bethesda and Executive Meeting Center
8120 Wisconsin Ave., Bethesda, MD 20814

Topic:  Strain Selection for the Influenza Virus Vaccine for the 2011-2012 Season

8:30 a.m.
Call to Order  Jose Romero, M.D.,Chair
8:35
Administrative RemarksDon Jehn, M.S., FDA
8:45
IntroductionJerry Weir, Ph.D., FDA
8:55
U.S. SurveillanceLisa Grohskopf, M.D., CDC
9:15
World Surveillance/Virus CharacterizationNancy Cox, Ph.D., CDC
10:00
DoD Vaccine Effectiveness Report  Kevin Russell, M.D., DOD
10:20
Break 
10:35
Vaccine ResponsesZhiping Ye, M.D., Ph.D., FDA
10:55
Availability of Vaccine Viruses & ReagentsWilliam McCormick, Ph.D., FDA
11:10
Comments from Manufacturers

Samson Lee, Ph.D., Sanofi Pasteur

11:30

Update on H5N1 and H9N2 Surveillance and Virus Characterization

Nancy Cox, Ph.D., CDC
11:50

Open Public Hearing

 
12:50 p.m.
Committee Discussion and Recommendations 
1:50
Update on Febrile Seizure Signal after Influenza Vaccine

David Martin, M.D., FDA

2:05
Meeting Adjournment